-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 16, Hefei Municipal Health Insurance Bureau issued the "Hefei, Anqing Alliance area drug centralized procurement announcement", will be hydrochloric acid moxisa star, cephalosporine, Qingkailing, injection of lansora, injection of omeprazole and other 14 in the clinical use of large, high procurement amount, full competition, clinical use of mature varieties for the first batch of centralized procurement.
the specific 14 varieties are as follows: procurement volume and procurement cycle, public medical institutions in accordance with the actual procurement volume in 2019 reported the annual commitment purchase volume of drugs in the catalog, agreed procurement volume according to the annual commitment of 70% of the procurement volume determined.
the procurement cycle for a period of 1 year, if the purchase volume agreed for the current year is completed in advance, more than the selected enterprises will still be in accordance with the winning price for supply, until the expiration of the procurement cycle.
declaration requirements, the declaration enterprise needs to participate in this centralized procurement activities within two years, in the drug production activities no serious illegal record, must be responsible for the quality of drugs, once selected, as the first responsible person for supply protection, should be timely and sufficient according to the requirements of the organization of production, and to send drugs to distribution enterprises, to meet the needs of medical institutions clinical drug use: 1. the annual production capacity of declared varieties to reach 2 times the quantity of this procurement (including) or more.
2. The declared varieties fall within the scope of the catalogue of purchased varieties and meet one of the following requirements: (1) the original research drug and the State Drug Administration issued generic drug quality and efficacy consistency evaluation reference preparation; (2) In the 2018 Annual Report of China Pharmaceutical Statistics (Comprehensive Book) "The legal entity units of industrial enterprises ranked according to the main business income of the pharmaceutical industry" the top 500 enterprises (including the enterprises owned by the Group, the group affiliation shall be subject to the "post-affiliation note of the legal entity of industrial enterprises" in the 2018 Annual Report of China Pharmaceutical Statistics (Comprehensive Book); not in item (2), but from January 1, 2019 to December 31, 2019, the declared varieties in Hefei, Anqing Alliance region with the same variety of platform procurement quantity of the top 3 enterprises (different specifications of product procurement volume combined calculation, based on the purchase of provincial pharmaceutical procurement platform, see Annex 1).
3. Enterprises must include the main rules specified in the catalogue of purchased varieties when declaring varieties.
the rules of the selection, according to the price to determine the pre-selected varieties: the same variety through the qualification examination of the number of enterprises , the lowest quotation only 1 enterprise, the enterprise's declared varieties to obtain pre-selection qualifications.
only 1 enterprise passed the qualification examination, directly to obtain the pre-selection qualification.
the enterprises that have obtained the pre-selection qualification and the qualified declared varieties, and enter the negotiation confirmation procedure sings in a unified manner.
through the qualification examination of the number of enterprises of the varieties of 3: pre-selected varieties declared price in line with the relevant requirements of this quotation, after confirmation by both parties (by the enterprise authorized representative and the evaluation expert group signed confirmation), to obtain the proposed selection qualification.
through the qualification examination of the number of enterprises , 2 varieties: (1) pre-selected varieties declared price decline from high to low in all pre-selected varieties in the top 50% (in case can not be divided from the reserved integer bit), after confirmation by both parties (by the enterprise authorized representative and evaluation expert group signed confirmation), to obtain the proposed selection qualification; If the declared price of
meets the requirements of the reduction and has been agreed upon, the proposed qualification can be obtained after confirmation by both parties (signed by the authorized representative of the enterprise and the expert group of evaluation). if the
do not participate in or do not accept the bargaining negotiations, the variety for the flow of standard processing, the joint procurement office to implement key monitoring of the relevant products, monthly publication of the procurement volume of various medical institutions, and included in the medical insurance audit supervision must check items.
.